Glycotranscriptome study reveals an enzymatic switch modulating glycosaminoglycan synthesis during B-cell development and activation

European Journal of Immunology

Volumn 41, Issue 12, 2011, Pages 3632-3644

  Duchez, Sophie ^a   Pascal, Virginie ^a   Cogné, Nadine ^a   Jayat Vignoles, Chantal ^a   Julien, Raymond ^a   Cogné, Michel ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

Animal model; B cells; B cell development; Cell surface molecules

Indexed keywords

CHONDROITIN SULFATE; ENZYME; EXOSTOSIN 1; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; IMMUNOGLOBULIN; N ACETYLGALACTOSAMINYL TRANSFERASE 1; N ACETYLGALACTOSAMINYLTRANSFERASE; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; MALE; MODULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CHONDROITIN SULFATES; GENETIC VARIATION; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; N-ACETYLGALACTOSAMINYLTRANSFERASES; N-ACETYLGLUCOSAMINYLTRANSFERASES; TUMOR SUPPRESSOR PROTEINS;

EID: 82255186834     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201140865     Document Type: Article

References (41)

1. Haines, N. and Irvine, K. D., Glycosylation regulates Notch signalling. Nat. Rev. Mol. Cell Biol. 2003. 4: 786-797.
2. Kurayoshi, M., Yamamoto, H., Izumi, S. and Kikuchi, A., Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling. Biochem. J. 2007. 402: 515-523.
3. Komekado, H., Yamamoto, H., Chiba, T. and Kikuchi, A., Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a. Genes Cells 2007. 12: 521-534.
4. Coombe, D. R. and Kett, W. C., Heparan sulphate-protein interactions: therapeutic potential through structure-function insights. Cell Mol. Life Sci. 2005. 62: 410-424.
5. Bandtlow, C. E. and Zimmermann, D. R., Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol. Rev. 2000. 80: 1267-1290.
6. Haltiwanger, R. S. and Lowe, J. B., Role of glycosylation in development. Annu. Rev. Biochem. 2004. 73: 491-537.
7. Ingold, K., Zumsteg, A., Tardivel, A., Huard, B., Steiner, Q. G., Cachero, T. G., Qiang, F. et al., Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 2005. 201: 1375-1383.
8. Ashikari, S., Habuchi, H. and Kimata, K., Characterization of heparan sulphate oligosaccharides that bind to hepatocyte growth factor. J. Biol. Chem. 1995. 270: 29586-29593.
9. Stringer, S. E. and Gallagher, J. T., Specific binding of the chemokine platelet factor 4 to heparan sulphate. J. Biol. Chem. 1997. 272: 20508-20514.
10. Tanaka, Y., Fujii, K., Hubscher, S., Aso, M., Takazawa, A., Saito, K., Ota, T. and Eto, S., Heparan sulphate proteoglycan on endothelium efficiently induces integrin-mediated T cell adhesion by immobilizing chemokines in patients with rheumatoid synovitis. Arthritis Rheum. 1998. 41: 1365-1377.
11. Gallagher, J. T., Lyon, M. and Steward, W. P., Structure and function of heparan sulphate proteoglycans. Biochem. J. 1986. 236: 313-325.
12. Spillmann, D., Witt, D. and Lindahl, U., Defining the interleukin-8-binding domain of heparan sulphate. J. Biol. Chem. 1998. 273: 15487-15493.
13. Proudfoot, A. E., Fritchley, S., Borlat, F., Shaw, J. P., Vilbois, F., Zwahlen, C., Trkola, A. et al., The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 2001. 276: 10620-10626.
14. Sakai, K., Kimata, K., Sato, T., Gotoh, M., Narimatsu, H., Shinomiya, K. and Watanabe, H., Chondroitin sulphate N-acetylgalactosaminyltransferase-1 plays a critical role in chondroitin sulphate synthesis in cartilage. J. Biol. Chem. 2007. 282: 4152-4161.
15. Ahn, J., Ludecke, H. J., Lindow, S., Horton, W. A., Lee, B., Wagner, M. J., Horsthemke, B. and Wells, D. E., Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat. Genet. 1995. 11: 137-143.
16. Lin, X., Wei, G., Shi, Z., Dryer, L., Esko, J. D., Wells, D. E. and Matzuk, M. M., Disruption of gastrulation and heparan sulphate biosynthesis in EXT1-deficient mice. Dev. Biol. 2000. 224: 299-311.
17. Kim, B. T., Kitagawa, H., Tamura, J., Saito, T., Kusche-Gullberg, M., Lindahl, U. and Sugahara, K., Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1, 4-N-acetylglucosaminyltransferases that likely are involved in heparan sulphate/heparin biosynthesis. Proc. Natl. Acad. Sci. USA 2001. 98: 7176-7181.
18. Engelmann, S., Ebeling, O. and Schwartz-Albiez, R., Modulated glycosylation of proteoglycans during differentiation of human B lymphocytes. Biochim. Biophys. Acta 1995. 1267: 6-14.
19. Kim, C. W., Goldberger, O. A., Gallo, R. L. and Bernfield, M., Members of the syndecan family of heparan sulphate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol. Biol. Cell 1994. 5: 797-805.
20. Sanderson, R. D., Lalor, P. and Bernfield, M., B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1989. 1: 27-35.
21. Theocharis, A. D., Seidel, C., Borset, M., Dobra, K., Baykov, V., Labropoulou, V., Kanakis, I. et al., Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J. Biol. Chem. 2006. 281: 35116-35128.
22. van der Voort, R., Keehnen, R. M., Beuling, E. A., Spaargaren, M. and Pals, S. T., Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulphate proteoglycans. J. Exp. Med. 2000. 192: 1115-1124.
23. Guglielmi, L., Truffinet, V., Carrion, C., Le Bert, M., Cogne, N., Cogne, M. and Denizot, Y., The 5'HS4 insulator element is an efficient tool to analyse the transient expression of an Em mu-GFP vector in a transgenic mouse model. Transgenic Res. 2005. 14: 361-364.
24. Chauveau, C., Pinaud, E. and Cogne, M., Synergies between regulatory elements of the immunoglobulin heavy chain locus and its palindromic 3' locus control region. Eur. J. Immunol. 1998. 28: 3048-3056.
25. Chauveau, C., Decourt, C. and Cogne, M., Insertion of the IgH locus 3' regulatory palindrome in expression vectors warrants sure and efficient expression in stable B cell transfectants. Gene 1998. 222: 279-285.
26. Guglielmi, L., Le Bert, M., Comte, I., Dessain, M. L., Drouet, M., Ayer-Le Lievre, C., Cogne, M. and Denizot, Y., Combination of 3' and 5' IgH regulatory elements mimics the B-specific endogenous expression pattern of IgH genes from pro-B cells to mature B cells in a transgenic mouse model. Biochim. Biophys. Acta 2003. 1642: 181-190.
27. Guglielmi, L., Le Bert, M., Truffinet, V., Cogne, M. and Denizot, Y., Insulators to improve expression of a 3(')IgH LCR-driven reporter gene in transgenic mouse models. Biochem. Biophys. Res. Commun. 2003. 307: 466-471.
28. Hardy, R. R., Kincade, P. W. and Dorshkind, K., The protean nature of cells in the B lymphocyte lineage. Immunity 2007. 26: 703-714.
29. Nutt, S. L. and Kee, B. L., The transcriptional regulation of B cell lineage commitment. Immunity 2007. 26: 715-725.
30. Shaffer, A. L., Lin, K. I., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M. et al., Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002. 17: 51-62.
31. Bea, S., Zettl, A., Wright, G., Salaverria, I., Jehn, P., Moreno, V., Burek, C. et al., Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005. 106: 3183-3190.
32. Moyron-Quiroz, J. E., Partida-Sanchez, S., Donis-Hernandez, R., Sandoval-Montes, C. and Santos-Argumedo, L., Expression and function of CD22, a B-cell restricted molecule. Scand. J. Immunol. 2002. 55: 343-351.
33. Garner, O. B., Yamaguchi, Y., Esko, J. D. and Videm, V., Small changes in lymphocyte development and activation in mice through tissue-specific alteration of heparan sulphate. Immunology 2008. 125: 420-429.
34. Langford, J. K., Stanley, M. J., Cao, D. and Sanderson, R. D., Multiple heparan sulphate chains are required for optimal syndecan-1 function. J. Biol. Chem. 1998. 273: 29965-29971.
35. Sanderson, R. D. and Bernfield, M., Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. Proc. Natl. Acad. Sci. USA 1988. 85: 9562-9566.
36. Shworak, N. W., Shirakawa, M., Colliec-Jouault, S., Liu, J., Mulligan, R. C., Birinyi, L. K. and Rosenberg, R. D., Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulphate. J. Biol. Chem. 1994. 269: 24941-24952.
37. Stanley, M. J., Liebersbach, B. F., Liu, W., Anhalt, D. J. and Sanderson, R. D., Heparan sulphate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. J. Biol. Chem. 1995. 270: 5077-5083.
38. Chauveau, C., Jansson, E. A., Muller, S., Cogne, M. and Pettersson, S., Cutting edge: Ig heavy chain 3' HS1-4 directs correct spatial position-independent expression of a linked transgene to B lineage cells. J. Immunol. 1999. 163: 4637-4641.
39. Matthias, P. and Baltimore, D., The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region. Mol. Cell. Biol. 1993. 13: 1547-1553.
40. Michaelson, J. S., Giannini, S. L. and Birshtein, B. K., Identification of 3' alpha-hs4, a novel Ig heavy chain enhancer element regulated at multiple stages of B cell differentiation. Nucleic Acids Res. 1995. 23: 975-981.
41. Pinaud, E., Khamlichi, A. A., Le Morvan, C., Drouet, M., Nalesso, V., Le Bert, M. and Cogne, M., Localization of the 3' IgH locus elements that effect long-distance regulation of class switch recombination. Immunity 2001. 15: 187-199.